[Updated from February 2018 post] Mobile technology lends many benefits to clinical research, including shortened study duration, more accurate data, and beyond. Keep reading for our perspective on the impact we can expect mobile apps to have as the industry advances.
CDS has many innovative updates in store for TrialKit in 2021. Check out this blog post for a quick glance at what’s to come to the platform in the upcoming year.
Making patient engagement more achievable will lead to more successful clinical trials. In this post, we detail four best practices in the TrialKit platform to help research teams reach optimal patient engagement.
A newer technique to the industry, bring your own device is approached with apprehension. In this post, we’ve identified four misconceptions about BYOD and provided explanations on each.
As we bid farewell to 2018 and begin rounding the corner to 2019, we find ourselves reflecting on all we’ve achieved this year. Our team enjoyed supporting research professionals worldwide as they built studies, deployed to sites around the globe, and continued to efficiently collect data using the platform’s latest technologies.
Fully-featured eClinical app, TrialKit, will soon be released on Google Play by Crucial Data Solutions, making clinical data collection and management possible on the majority of smartphones available today.
Surrounding the industry shift to make clinical trials more patient-centric, there has been a drastic increase in the adoption of eCOA and ePRO solutions. We highlight just a few of their benefits in this post.
Research professionals now have access to enhanced capabilities, such as adjudication and risk-based monitoring, on mobile devices with Crucial Data Solutions’ most recent update for TrialKit on iOS.
TrialKit’s ePRO functionality, now available for download on Google Play, can be easily accessed by clinicians and patients alike from any smartphone or tablet.